Skip to main content

Table 1 Relationship between patient intratumor Cul4B and clinicopathologic features

From: Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1

Variable Intratumor Cul4B
Low expression (n = 64) High expression (n = 64) p
Age (years)
 < 50 13 21 0.109
 ≥50 51 43  
Pathological type
 Non-serous tumour 37 32 0.375
 Serous tumour 27 32  
Tumor grade
 1 10 9 0.804
 2–3 54 55  
Tumor size
 < 10 cm 24 25 0.856
 ≥10 cm 40 39  
FIGO
 I-II 50 39 0.035
 III-IV 14 25  
CA125
 < 70 U/L 27 29 0.581
 ≥70 U/L 36 35